Catalyst Wire Dossier Catalyst Wire Dossier

Isa-V-Iberdomide

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Isa-V-Iberdomide, covering 2022-09-28 to 2022-09-28. Get the full timeline:

Most recent: Clinical Trial Update: NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide [Phase 3]

See pricing